Benefits of Electronic Prescribing Software for Dentists

Posted by on Comments (0)

Electronic prescribing has many advantages for dentists and dental offices. Sending prescriptions electronically can drastically improve a dentist’s workflow by being able to transmit prescriptions to the pharmacy quickly and efficiently, avoiding the traditional stresses of writing out paper prescriptions, making phone calls, or dealing with pages of faxes.

 

Here are five ways MDToolbox offers one of the best e-Prescribing software services to save dental practices time & money:

 

Dental e-prescribing allows dentists to improve the safety and quality of care they provide. 

Patients may remember to bring their medication list with them to see their cardiologist but might not remember their list when seeing the dentist. Some electronic prescribing systems (such as MDToolbox) allow for pulling medication fill history for patients automatically, so even if the patient cannot recall their medications, the dentist will have a record of it. MDToolbox can improve patient safety by alerting for any drug to drug interactions, drug allergy interactions, drug to condition interactions, and duplicate therapy conditions. These alerts could save a patient’s life.

 

MDToolbox allows for checking State PMPs in one click.

The opioid epidemic plaguing our country has resulted in many states mandating checking the state specific Prescription Drug Monitoring Programs (PMPs) prior to prescribing certain controlled substance medications. MDToolbox allows dentists in most states to be able to check this data directly within the prescription writer, saving dentists time when they could be seeing patients.

 

Dental practices require different software than traditional medical offices.

MDToolbox offers a stream-lined stand-alone solution to electronic prescribing without the extensive, steep learning curve of a full EMR. Quickly accessing a patient file and sending a prescription to the pharmacy can be invaluable to an efficient workflow in a modern dental practice. Prescribers will also find dental-specific medication monograph data when looking up drug information in the program.

 

Electronic prescribing saves patient’s money, which may help when the Nitrous Oxide wears off.

 MDToolbox offers real-time pricing benefit from directly within our system. This allows for viewing the price of the specific medication the dentist is prescribing at their patient’s specific pharmacy as they are writing the prescription. The system will present potential alternatives that may save the patient money by making a brand or pharmacy change.

 

Meet State and National mandates to electronically prescribe.

States are continuing to pass legislation requiring all prescribers, including dentists, to send electronic prescriptions. See our State Map for information on current and pending legislation. Some States detail extensive penalties for not complying with their electronic prescribing legislation. In addition, the Substance Use-Disorder Prevention that Promotes Opioid Recovery and Treatment (SUPPORT) for Patients and Communities Act will require EPCS at the national level starting in January 2021.

 

MDToolbox looks forward to providing tools and resources to assist dentists throughout the United States to ease the transition, helping our customers increase the efficiency of their office and combat the opioid epidemic. With MDToolbox, dentists have access to tools such as Electronic Prescribing of Controlled Substances (EPCS), the ability to check most State’s PMPs without having to separately login to their State portal, and convenient on the go e-prescribing with our mobile app! We offer a free 30 day free trial, so Contact us for more information!

MDToolbox Awarded Best Value, Best Ease of Use, and Best Functionality & Features

Posted by on Comments (0)

MDToolbox is proud to announce that we have recently won three awards for our electronic prescribing platform!

 

Capterra, a free online service that helps organizations find the right software, has awarded MDToolbox both their “Best Value” and “Best Ease of Use” awards for 2020.  These were independently assessed based on user reviews and online search activity amongst the electronic prescribing software market. The awards are only given to software companies whose products reach an average review rating score greater than 4.5 across all of the products’ published reviews within the submission period.

 

 

 

In our Capterra reviews, Valori C. stated “…there are not enough superlatives to describe this product and its affordability.”  MDToolbox is extremely proud to be recognized for Best Value for electronic prescribing, as we concentrate on providing the most affordable option on the market without sacrificing features or generating secondary income off our users by including ads or selling their patient data. With MDToolbox, our focus is solely on providing software that healthcare providers can rely on, so they can focus on what really matters – patient care.

 

Ease of Use is something difficult to achieve considering the myriad of regulations that come with electronic prescribing. MDToolbox engineers are constantly striving to lessen the learning curve for electronic prescribing. Noreene R. said “I was able to figure out how to use it on my own when my secretary was out for a week. The ease of operation is really impressive and there are so few steps to complete the transaction. We are very happy that we chose this system.” 

 

However, if that learning curve is still too steep for some users, MDToolbox prides itself on having some of the best customer support in the market with average hold-times of under 30 seconds.  Our support staff are happy to assist our users better utilize the system to make their medical practice as efficient as possible.            

 

GetApp, a sister site of Capterra that also focuses on helping professionals find the right software, has awarded MDToolbox their “Best Functionality and Features” award for 2020.  GetApp calculated scores for their award based on user reviews and product features evaluated by a research analyst.

 

 

Julie B. wrote “The ease of use is the most important thing that I liked about the software. Also the feature of notifying the pharmacy of discontinuing the medication. That is a feature I did not have on the other software I used. I can also track the medication from escribing through to the pharmacy's acceptance which is great.”

 

MDToolbox has remained a frontrunner for adopting new features and certifying to industry standards.  MDToolbox staff are driven to provide as many useful features as possible while our engineers are ensuring the stable functionality that is imperative to the modern medical practice. State Prescription drug Monitoring Program (PMP) integration, real-time prescription benefit information, compounded-drug prescribing, and drug interaction alerts are just some of the included advanced features that make MDToolbox stand out as a superior electronic prescribing system.

 

We’re thankful to all of our users who’ve left us such great reviews and aim to continue providing the best e-prescribing software we can. Please see Capterra for our full reviews and if you’re ready to check out our award-winning software yourself, make sure to sign up for our free 30 day trial!

 

The Best badge recipients are determined by the subjective opinions of individual end-user customers based on their own experiences, the number and timing of published reviews on Gartner’s digital sites (Capterra.com, SoftwareAdvice.com, and GetApp.com) and review ratings for a given product in the category, and are not intended in any way to represent the views of Gartner or its affiliates.

DEA Confirms Providers Can Prescribe Controlled Substances Via Telemed

Posted by on Comments (0)

The Department of Health and Human Services (HHS) and the Drug Enforcement Administration (DEA) have released clarification of United States Code contained in the Controlled Substances Act affecting Telehealth visits. 

 

President Trump in a Tuesday briefing said his administration would "encourage everyone to maximize use of telehealth to limit exposure to the virus."

 

The DEA has clarified that during a Public Health Emergency, which was issued by Secretary Azar of HHS on January 31st, 2020 due to the COVID-19 virus, that controlled substances may be prescribed via telemedicine without first conducting an in-person visit with the patient.  The Ryan Haight Act of 2008 established regulations and prohibited heathcare providers from prescribing controlled substances to patients that they haven’t first examined in-person.  Section 802(54)(D) of the Controlled Substances Act allows for the Ryan Haight Act to be circumvented during a public health emergency which would allow MDToolbox customers to electronically prescribe controlled substances (EPCS) for patients via telemedicine.

 

The DEA has stated three conditions for prescribing controlled substances via telemedicine:

  • The prescription is issued for a legitimate medical purpose by a practitioner acting in the usual course of his/her professional practice
  • The telemedicine communication is conducted using an audio-visual, real-time, two-way interactive communication system.
  • The practitioner is acting in accordance with applicable Federal and State law.

 

Not all States allow for EPCS via telemedicine, prescribers will need to ensure that they are following both their State law as well as the State law where the patient resides prior to prescribing via telemedicine.  Some states that allow for EPCS via telemedicine include Indiana, Michigan, Ohio, Florida, Delaware, New Hampshire, West Virginia, and Connecticut.  Prescribers should contact their State Medical and Pharmacy Boards as well as the State Boards where their patient resides to ensure their compliance.

 

HHS has also issued further clarification on the systems that can be used for a telemedicine visit, they have ensured penalties will not be enforced for using apps such as:

  • Apple FaceTime
  • Facebook Messenger video chat
  • Google Hangouts video
  • Skype

 

This is not an inclusive list and are examples of apps that can be used.  The app must be a private communication means that support both audio and video.  The DEA provided further clarification that public communication apps or streaming services are not to be used such as:

  • Facebook Live
  • Twitch
  • TikTok

 

The DEA has missed several deadlines to establish rules and a waiver system to allow electronic prescribing of controlled substances via telemedicine during a time in which we are not in a Public Health Emergency.  Reducing these road-blocks, as we are seeing with the emergency measures in place due to COVID-19 can help bring healthcare into the 21st century and help reduce stress on our medical system as well as help prevent infections.

 

We at MDToolbox applaud HHS and the DEA for removing the telemedicine restrictions and our team are watching for more regulation changes on a federal level that would allow electronic prescription of controlled substances via a telehealth practitioner.  You will find any policy and regulation updates here in our blog.  MDToolbox looks forward to working with telehealth providers and help provide tools and resources in combating healthcare system strain.  Contact us for more information or to start your free 30 day free trial.

TELEMEDICINE & EPCS: New Regulations Coming in Fall 2019!

Posted by on Comments (0)

 

While the United States government has been writing legislation to control addictive drugs since the early 1900’s, The Controlled Substances Act (CSA) of 1970 laid the groundwork for how controlled substances are regulated.  The CSA established the schedule system that is still used today for drug classification.  The act also established policy for regulations on the manufacture, importation, possession, use, and distribution of scheduled substances.  The CSA has been amended 9 times since its enactment, the eighth amendment in 2008 was titled The Ryan Haight Online Pharmacy Consumer Protection Act which brought portions of the CSA into the digital age.

The Ryan Haight Act amends the CSA to prohibit the delivery, distribution, and dispensing of controlled substances over the internet without a valid prescription.  The Ryan Haight Act forces online pharmacies to report their controlled substance prescriptions to the Attorney General and requires that online pharmacies to display compliance information on their website.  There are several definitions established in the Act, one of the most important being that a “valid prescription” must come from a practitioner that has conducted at least one in-person medical visit with the patient.  As technology has advanced and telehealth has risen in popularity, this section of the Act has created issues for digital practitioners that may never see their patient in face to face.

The Ryan Haight Act also contains a “Special Registration for Telemedicine” section that tasked the Attorney General to issue certain regulations to allow the prescribing of controlled substances without an in-person consult.  The Attorney General has not issued an update on this provision since the Ryan Haight Act was written and enacted in 2008.  Some States have taken that responsibility upon themselves to rule on controlled substances being issued by telemedicine such as Indiana, Michigan, Ohio, Florida, Delaware, New Hampshire, West Virginia, and Connecticut[1].  These states passed legislation allowing for controlled substances to be prescribed via telehealth without seeing the patient in-person so long as certain requirements are met.  The state laws contradict the federal law that the Ryan Haight Act established and there is uncertainty what the legal ramifications might be in court.

In 2018, President Trump signed the Substance Use-Disorder Prevention that Promotes Opioid Recovery and Treatment for Patients and Communities Act, also known as the SUPPORT Act.  The Support Act contains legislative changes for many aspects of healthcare including Medicaid and Medicare, funding the CURES Act, an EPCS mandate, State PMP requirements, and many more.  The Support Act also finally sets a date for the telehealth controlled-substance exemptions to be written that were established in the Ryan Haight Act of 2008.  The Support Act requires the Attorney General write the final regulations that specify “the limited circumstances in which a special registration under this subsection may be issued” and “the procedure for obtaining a special registration”[2].  The deadline for the Attorney General to establish these regulations is October 24th, 2019.

We don’t exactly know what the regulations and restrictions will look like or how stringent the requirements for a telehealth provider to prescribe a controlled substance without an in-person visit will be until fall of this year.  The federal regulations could follow some of the State-level legislation or could be in contrast and create a necessary change for telehealth prescribers in those states who have attempted to setup their practice following their State’s laws.

We at MDToolbox are watching for any regulation changes on a federal level that would allow electronic prescription of controlled substances via a telehealth practitioner.  You will find any policy updates here in our blog.  MDToolbox looks forward to working with telehealth providers and help provide tools and resources in combating the opioid epidemic. Contact us for more information or to start your free 30 day free trial.

[1]https://www.healthcarelawtoday.com/2018/06/27/new-connecticut-law-allows-telemedicine-prescribing-of-controlled-substances/

[2]https://www.congress.gov/bill/115th-congress/house-bill/6/text#toc-HA8EADE1EA6CF4E62B8D435826C060821